✦ LIBER ✦

5529 POSTER Hyperfractionated radiation therapy and cisplatin for locally-advanced head and neck cancer (LAHNC). Experience of the Hospital de Navarra

✍ Scribed by Arias, F.; Dominguez, M.A.; Villafranca, E.; Romero, P.; Manterola, A.; Martínez, E.; Oria, E.; Asin, G.; Rico, M.; Arrarás, J.I.

Book ID: 122859720
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 57 KB
Volume: 5
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(07)71246-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 trial of concurrent 5-fluorourac

Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer

✍ Johnny Kao; Eric M. Genden; Vishal Gupta; Edelweiss L. Policarpio; Ryan J. Burri 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB

Comparison of Every 3 Week Cisplatin or

Comparison of Every 3 Week Cisplatin or Weekly Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head-and-Neck Cancer

✍ Strom, T.J.; Trotti, A.M.; Kish, J.; Rao, N.G.; McCaffrey, J.C.; Padhya, T.A.; O 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 50 KB

785 Poster Accelerated fractionation wit

785 Poster Accelerated fractionation with concomitant boost (AFX-C) and concurrent Cisplatin, for locally advanced, unresectable, head and neck cancer (LAHNC). Preliminary report of a phase II trial

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 152 KB

A Phase I Study of SPI-077 (Stealth® Lip

A Phase I Study of SPI-077 (Stealth® Liposomal Cisplatin) Concurrent with Radiation Therapy for Locally Advanced Head and Neck Cancer

✍ David I. Rosenthal; Sue S. Yom; Li Liu; Mitchell Machtay; Kenneth Algazy; Randal 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 76 KB

Hyperfractionated radiation therapy and

Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (± granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma

✍ André A. Abitbol; Kasi S. Sridhar; Alan A. Lewin; James G. Schwade; William Raub 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 3 views

initial entry of 34 patients. Cancer Center, University of Miami School of RESULTS. At a median follow-up of 41 months (range, 12-80 months), 44 patients Medicine, Miami, Florida. were alive with a projected median overall survival of 54 months. Grade 3/4 muco-2 Regional Cancer Center, Baptist Hosp

Hyperfractionated accelerated radiation

Hyperfractionated accelerated radiation therapy with concurrent interferon alpha and isotretinoin for patients with locally advanced squamous cell carcinoma of the head and neck

✍ J. Vrouvas; G. Kolitsi; C. Kyprianou; Ph. Angelakis 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 123 KB